O'Shaughnessy Asset Management’s Filana Therapeutics FLNA Stock Holding History

O'Shaughnessy Asset Management’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-493	Closed	-$31K	–	2246
2021 Q3	$31K	Buy	+493	New	+$41.1K	﹤0.01%	1819
2021 Q2	–	Sell	-608	Closed	-$27K	–	2680
2021 Q1	$27K	Buy	608 +547	+897%	+$21.5K	﹤0.01%	1575
2020 Q4	$0	Buy	+61	New	+$545	﹤0.01%	2211

Other funds holding FLNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

O'Shaughnessy Asset Management's FLNA Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of Filana Therapeutics (FLNA) in Q4 2021, closing a stake of 493 shares — an estimated $31K sold.

O'Shaughnessy Asset Management first reported a position in FLNA in Q4 2020 and held it in 3 quarters. The position peaked at $31K in Q3 2021. 171 funds tracked by Wall St. Rank hold FLNA as of Q4 2021.

O'Shaughnessy Asset Management reported no remaining Filana Therapeutics position as of Q4 2021 after selling out during the quarter.
O'Shaughnessy Asset Management sold 493 Filana Therapeutics shares in Q4 2021, an estimated $31K.
O'Shaughnessy Asset Management first reported a position in Filana Therapeutics in Q4 2020 and held it in 3 quarters.
O'Shaughnessy Asset Management's Filana Therapeutics position peaked at $31K in Q3 2021.
171 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.